急性髓系白血病中的环形铁粒幼红细胞与不良风险特征及独特基因表达模式相关
本研究旨在表征急性髓系白血病(AML)患者中的环形铁粒幼红细胞(RS)。临床上,RS-AML富集ELN不良风险(55%),35%病例有复杂细胞遗传学异常,TP53突变最常见(37%)。与RS-MDS不同,SF3B1突变率低(8%)。全外显子测序和SNP阵列未发现单一遗传缺陷解释RS表型。RNA测序显示RS-AML与非RS-AML的CD34+细胞基因表达差异,包括巨核和红系分化基因,且血红素代谢相关基因上调,与SF3B1突变MDS相似。
要点
- RS-AML多属ELN不良风险,常伴复杂核型和TP53突变。
- RS-AML中SF3B1突变率低,不同于RS-MDS。
- RS-AML与RS-MDS共享下游血红素代谢通路异常。
核心结论
- RS-AML遗传背景与RS-MDS不同,但共享某些下游效应通路。
研究设计与样本
- 对AML患者进行临床和遗传学特征分析,包括测序和RNA测序。
主要发现
- RS-AML中ELN不良风险占55%,复杂核型占35%,TP53突变占37%,DNMT3A占26%,RUNX1占25%,TET2占20%,ASXL1占19%。
- RS-AML中SF3B1突变率为8%。
- 全外显子测序和SNP阵列未发现单一遗传缺陷解释RS表型。
- RNA测序显示RS-AML与非RS-AML的CD34+细胞基因表达差异,涉及巨核和红系分化基因。
- RS-AML的CD34+细胞中血红素代谢相关基因上调,与SF3B1突变MDS相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ring sideroblasts (RS) emerge as result of aberrant erythroid differentiation leading to excessive mitochondrial iron accumulation, a characteristic feature for myelodysplastic syndromes (MDS) with mutations in the spliceosome gene SF3B1. However, RS can also be observed in patients diagnosed with acute myeloid leukemia (AML). The objective of this study was to characterize RS in patients with AML. Clinically, RS-AML is enriched for ELN adverse risk (55%). In line with this finding, 35% of all cases had complex cytogenetic aberrancies, and TP53 was most recurrently mutated in this cohort (37%), followed by DNMT3A (26%), RUNX1 (25%), TET2 (20%), and ASXL1 (19%). In contrast to RS-MDS, the incidence of SF3B1 mutations was low (8%). Whole-exome sequencing and SNP array analysis on a subset of patients did not uncover a single genetic defect underlying the RS phenotype. Shared genetic defects between erythroblasts and total mononuclear cell fraction indicate common ancestry for the erythroid lineage and the myeloid blast cells in patients with RS-AML. RNA sequencing analysis on CD34+ AML cells revealed differential gene expression between RS-AML and non RS-AML cases, including genes involved in megakaryocyte and erythroid differentiation. Furthermore, several heme metabolism-related genes were found to be upregulated in RS- CD34+ AML cells, as was observed in SF3B1mut MDS. These results demonstrate that although the genetic background of RS-AML differs from that of RS-MDS, they have certain downstream effector pathways in common.
引用
- Berger G, Gerritsen M, Yi G, et al. Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood Adv. 2019. PMID: 31648334. doi:10.1182/bloodadvances.2019000518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。